ASTEC LIFESCIENCES
|
ASTEC LIFESCIENCES Last 5 Year Financial Ratios History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | 13.04 | 45.85 | 33.21 | 24.28 | 18.28 |
CEPS(Rs) | 30.22 | 63.39 | 46.32 | 36.13 | 28.19 |
DPS(Rs) | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 |
Book NAV/Share(Rs) | 213.72 | 202.17 | 157.63 | 125.66 | 103.16 |
Tax Rate(%) | 26.76 | 25.79 | 26.95 | 22.53 | 36.02 |
Margin Ratios | |||||
Core EBITDA Margin(%) | 12.08 | 22.66 | 19.94 | 16.21 | 17.67 |
EBIT Margin(%) | 8.82 | 19.15 | 16.79 | 14.07 | 15.78 |
Pre Tax Margin(%) | 5.54 | 17.82 | 15.94 | 11.67 | 12.92 |
PAT Margin (%) | 4.05 | 13.22 | 11.64 | 9.04 | 8.27 |
Cash Profit Margin (%) | 9.39 | 18.27 | 16.24 | 13.45 | 12.74 |
Performance Ratios | |||||
ROA(%) | 2.69 | 11.21 | 10.42 | 9.20 | 8.18 |
ROE(%) | 6.28 | 25.50 | 23.46 | 21.24 | 19.31 |
ROCE(%) | 7.75 | 22.21 | 22.29 | 20.44 | 20.31 |
Asset Turnover(x) | 0.66 | 0.85 | 0.89 | 1.02 | 0.99 |
Sales/Fixed Asset(x) | 1.31 | 1.72 | 1.91 | 2.14 | 2.33 |
Working Capital/Sales(x) | -23.08 | 27.10 | 68.53 | 39.26 | -1,324.35 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 0.76 | 0.58 | 0.52 | 0.47 | 0.43 |
Receivable days | 123.89 | 123.70 | 113.66 | 98.14 | 103.32 |
Inventory Days | 139.29 | 78.67 | 74.22 | 74.31 | 72.27 |
Payable days | 166.93 | 150.04 | 176.37 | 143.21 | 106.55 |
Valuation Parameters | |||||
PER(x) | 106.02 | 38.22 | 30.12 | 16.47 | 29.47 |
PCE(x) | 45.75 | 27.64 | 21.60 | 11.07 | 19.11 |
Price/Book(x) | 6.47 | 8.67 | 6.35 | 3.18 | 5.22 |
Yield(%) | 0.11 | 0.09 | 0.15 | 0.38 | 0.28 |
EV/Net Sales(x) | 4.85 | 5.49 | 3.87 | 1.68 | 2.85 |
EV/Core EBITDA(x) | 34.14 | 22.56 | 17.95 | 9.06 | 14.01 |
EV/EBIT(x) | 54.78 | 28.51 | 22.86 | 11.90 | 17.97 |
EV/CE(x) | 3.11 | 4.01 | 3.17 | 1.54 | 2.66 |
M Cap / Sales | 4.31 | 5.08 | 3.53 | 1.50 | 2.44 |
Growth Ratio | |||||
Net Sales Growth(%) | -7.15 | 21.93 | 6.17 | 21.28 | 17.23 |
Core EBITDA Growth(%) | -45.72 | 37.72 | 23.03 | 10.82 | 13.95 |
EBIT Growth(%) | -57.24 | 38.76 | 26.88 | 8.30 | 2.87 |
PAT Growth(%) | -71.53 | 38.13 | 36.91 | 32.89 | 2.08 |
EPS Growth(%) | -71.56 | 38.07 | 36.78 | 32.84 | 2.26 |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | 0.81 | 0.71 | 0.61 | 0.40 | 0.87 |
Current Ratio(x) | 0.95 | 1.05 | 1.03 | 1.04 | 1.00 |
Quick Ratio(x) | 0.39 | 0.67 | 0.70 | 0.66 | 0.63 |
Interest Cover(x) | 2.69 | 14.37 | 19.75 | 5.87 | 5.52 |
Total Debt/Mcap(x) | 0.13 | 0.08 | 0.10 | 0.13 | 0.17 |
Compare Financial Ratios of peers of ASTEC LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ASTEC LIFESCIENCES | ₹2,434.3 Cr | -2.1% | 21.8% | -5.6% | Stock Analytics | |
PI INDUSTRIES | ₹56,277.6 Cr | 2.7% | 3.3% | 29% | Stock Analytics | |
UPL | ₹36,554.6 Cr | 0.9% | -4.8% | -33.6% | Stock Analytics | |
BAYER CROPSCIENCE | ₹25,689.8 Cr | 2.3% | -13.6% | 27.1% | Stock Analytics | |
SUMITOMO CHEMICAL INDIA | ₹19,995.8 Cr | 1.5% | -9.4% | -15% | Stock Analytics | |
BASF INDIA | ₹15,622.4 Cr | -1.7% | -1.6% | 36.1% | Stock Analytics |
ASTEC LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ASTEC LIFESCIENCES | -2.1% |
21.8% |
-5.6% |
SENSEX | -2.6% |
-0% |
21% |
You may also like the below Video Courses